Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Browse Articles or use Lyrarc's US patented "Groups" and "Links" for new insights. A Lyrarc Group of Articles on a topic gives insights into particular angles shown in the Group Title. A Lyrarc Link shows more specific insights for 2 articles.
Linked Articles
McConnell warns that trade deal can’t pass Congress before 2016 elections - The Washington Post
Washington Post 12/11/2015
Lawmakers Introduce ‘Fast Track’ Trade Bill, Triggering Democratic DiscordWall Street Journal 04/17/2015
Linked Articles
Pacific Trade Pact Revives Ghosts of Nafta Jobs Fight
Wall Street Journal 04/24/2015
No Big DealNew York Times 02/27/2014
Linked Articles
The New Nasdaq Record, Set By a New Nasdaq
Wall Street Journal 04/24/2015
Surging Nasdaq Pierces 4000Wall Street Journal 11/28/2013
The particular need to help the elderly in an aging population for China. The elderly suffer most from the need to set aside a large portion of savings for healthcare costs (Orlik).
Linked Articles
Politics Is a Bitter Pill for Glaxo
Wall Street Journal 07/25/2013
Aging Chinese Face a Bleak PictureWall Street Journal 05/31/2013
Linked Articles
China's Li Lays Out the Pledges
Wall Street Journal 03/17/2013
China Broadcaster Shows Up Apple, VWWall Street Journal 03/15/2013
Linked Articles
Chief Justice John Roberts’s health-care ruling gets plenty of second-guessing - The Washington Post
Washington Post 06/30/2012
Charles Lane: John Roberts’s Compromise of 2012 - The Washington PostWashington Post 06/30/2012
Without a new approach to increasing health care costs, especially considering the demographic changes in the U.S. with more people on Medicare in future years, the problems of defunding other areas such as education, R&D, and infrastructure, to fund these increases is likely to continue. Estimates show that the 50 million Americans enrolled in Medicare in 2012 will grow to 80 million by 2030, according to the Medicare program actuaries. Demographic changes as the baby boom generation ages mean more Americans relying on Medicare and Medicaid. With continually increasing health care costs from costly technologies, increasing of diabetes, asthma and other diseases, pricing in the medical industry, and some fraud costs, this is a toxic mix that will lead to to a situation where one of three dollars in spending get swallowed up here.
Linked Articles
Beneath Budget Battle, a Health-Spending Juggernaut
Wall Street Journal 12/17/2012
What to Do on the Day After ObamaCareWall Street Journal 04/03/2012
Linked Articles
44 Percent of Americans Approve of Supreme Court in New Poll
New York Times 06/07/2012
Justices Question Extent of Federal PowerWall Street Journal 03/29/2012
Linked Articles
Largest health insurer to keep key parts of law regardless of court ruling - The Washington Post
Washington Post 06/11/2012
- The Washington PostWashington Post 03/23/2012
Linked Articles
China Names Its New Foreign Policy Team
New York Times 03/16/2013
New Push for Reform in ChinaWall Street Journal 02/23/2012
Israel's Teva Pharmaceutical is the world's largest maker of generic drugs, followed by Watson Pharmaceuticals and Novarti's Sandoz unit.
Linked Articles
Wall Street Journal 05/08/2012
Former Test-Tube Washer Built Generic-Drug Maker TevaWall Street Journal 11/23/2011
Efforts to tap into the latest external science at universities and research centers outside company labs is leading pharmaceutical companies to try a different approach to R&D. Pfizer closed its R&D facility in Sandwich, England and opened one in Cambridge. It opened hubs in Boston, La Jolla. Merck has followed this approach with a decision to setup innovaton hubs in Boston, San Francisco, London and Shanghai.
Linked Articles
Merck Plans Radical Overhaul of Drug R&D Unit
Wall Street Journal 12/28/2013
Life Beyond Lipitor for Pfizer ChiefWall Street Journal 05/02/2011
Linked Articles
GOP Hopefuls Betting Voters Want Deep Cuts
Wall Street Journal 07/18/2011
Ludicrous and CruelNew York Times 04/07/2011
Linked Articles
Engage Girls With Tech Education, Leadership Early, Women CIOs Say
Wall Street Journal 12/04/2014
Even Scandinavia Has a CEO Gender GapWall Street Journal 05/23/2014
In a recent CBS/NYT poll 57% of the uninsured say it will increase their healthcare costs, only 20% of the uninsured say it will decrease their costs. A third of the uninsured say they will pay the penalty and not sign up for coverage under the law.
Linked Articles
Uninsured Skeptical of Health Care Law in Poll
New York Times 12/18/2013
Growth in U.S. Health Care Spending SlowsNew York Times 12/18/2013
Linked Articles
Wall Street Journal 11/28/2013
Four Reasons Why Nasdaq 4000 Differs From Tech BubbleWall Street Journal 11/26/2013
Linked Articles
China's Li Lays Out the Pledges
Wall Street Journal 03/17/2013
China Names Its New Foreign Policy TeamNew York Times 03/16/2013
After a decade of decline in consumer spending in favor of infrastructure spending to where it is now only 35% of GDP, or half that in the U.S. as a percentage of GDP, China's leadership realizes the need to help consumers. It is seen as high on the list of priorities for the Party's survival. Ordinary Chinese, rural households and the elderly are seriously affected by the high cost of healthcare and the need to set aside a large portion of savings for medical emergencies (Orlik). This further depresses consumer after the impact of low savings rates. With a bursting of the property bubble the money depositors shifted to real estate is also at risk for middle class investors.
Linked Articles
Wall Street Journal 10/03/2012
Politics Is a Bitter Pill for GlaxoWall Street Journal 07/25/2013
Linked Articles
Roberts Straddles Ideological Divide
Wall Street Journal 06/29/2012
Supreme Court upholds health-care law, individual mandate - The Washington PostWashington Post 06/28/2012
New York Mayor Bloomberg, and an editorial in the Washington Post after the Supreme Court hearings on the health care mandate and Medicaid expansion, describe the challenge facing America. The political class in the U.S. is quite content with promising something for nothing, which Bloomberg calls delusional.
Linked Articles
The Supreme Court’s civics lesson - The Washington Post
Washington Post 03/30/2012
Federal Budgets and Class WarfareWall Street Journal 03/29/2012
Linked Articles
Justices Question Extent of Federal Power
Wall Street Journal 03/29/2012
A Constitutional AwakeningWall Street Journal 03/29/2012
Cochrane points to regulations and laws that support high prices of medical carein the U.S., by reducing competition and restricting supply of doctors and suppliers of medical care. He says the mandate most likely would not even be necessary under such a system because the costs of healthcare in the U.S. would be so much lower.
Linked Articles
What to Do on the Day After ObamaCare
Wall Street Journal 04/03/2012
Why an MRI costs $1,080 in America and $280 in France - The Washington PostWashington Post 03/05/2012
The ideas and thinking of China's leaders and how this will affect China and the global economy.
Linked Articles
Heartland Return for Chinese Leader
Wall Street Journal 01/31/2012
Next Premier Came of Age in Era of OpennessWall Street Journal 11/16/2012
In the Wickard-Filburn decision the U.S. Supreme Court unanimously ruled against an Ohio farmer, Mr. Filburn, who questioned a federal law that imposed a penalty for every extra bushel of wheat grown beyond a stipulated amount. The briefs presented by both parties present arguments about what are the limits of federal power under its powers to regulate interstate commerce and in what circumstances- with the Obama administration arguing that it imposes larger costs on people in all states if some people refuse to buy insurance.
Linked Articles
At Center of Health Care Fight, Roscoe Filburn's 1942 Case
New York Times 03/19/2012
Health Insurance and the Broccoli TestNew York Times 11/15/2011
Rockoff's interview with Pfizer CEO, Ian Read, in which Read describes his strategy of focussing on new drug development and locating closer to hubs with large universities and research centers such as La Jolla, Cambridge, Massachusetts, and Cambridge, England. Pfizer sold its infant nutrition business to Nestle as part of this plan.
Linked Articles
Pfizer Profit Declines 19% After Loss of Lipitor Patent
New York Times 05/01/2012
Life Beyond Lipitor for Pfizer ChiefWall Street Journal 05/02/2011
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1